abstract |
The present invention relates to substituted isoquinolines and isoquinolines of formula (I) for use in the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase-mediated myosin light chain phosphatase phosphorylation Linones and compositions containing these compounds. |